참고자료

[돼지독감] WHO 가짜 신종플루 스캔들 조사단, 편향된 인사 포함 논란

WHO의 돼지독감(신종플루) 바이러스 대응을 검토하는 전문가 패널의 대표를 맡고 있는 하비 파인버그 박사가 200명의 패널 조사단 중 29명이 이해관계의 상충에 따라 이 문제를 다룰 것이라는 우려를 밝혔다는 AP통신의 4월 14일자 보도입니다.

하비 파인버그(Harvey Fineberg) 교수 현재 독립적인 비영리 기구인 의학연구소(the Institute of Medicine, http://www.iom.edu/) 소장을 맡고 있습니다. 하버드 의대 학장으로 재직했으며,  미국 국립보건원장을 역임한 바 있습니다. 1976년 미국의 돼지독감 사태에 대해 미 보건복지교육부 보고서 『돼지 독감 사태: 허깨비 전염병에 대한 의사결정과정(The Swine Flu Affair: Decision-Making on a Slippery Disease, U.S. Department of Health, Education, and Welfare)』, (Neustadt, Richard E, Fineberg Harvey V, 1978)의 저자 중의 한 명으로 유명합니다. 

그는 매커릿 찬(Margaret Chan ) WHO 사무총장이 임명하 200명의 조사단 가운데 적어도 10명은 과거나 현재 WHO에 자문을 하였던 적이 있으며, 24명의 위원은 정부에 고용된 적이 있기 때문에 궁극적으로 편향된 성향을 나타낼 수 밖에 없을 것이라는 우려를 밝혔습니다.

런던에 기반을 둔 국제정책네트워크(International Policy Network)라는 단체의 필립 스티븐스(Philip Stevens)도 일반적으로 봤을 때 WHO가 자신의 정책을 재검토하는 위원회에서 결론을 미리 정해놓고 그 결론에 짜맞추는 것 같은 방식으로 일처리를 했던 역사를 가지고 있다는 비파적 견해를 제시했다고 합니다.

결국 이러한 우려들은 ‘WHO의 가짜 신종플루 대유행 스캔들 조사’가 제대로 이루어질 수 없다느 비관적 현실을 반영하는 것이라 생각합니다.

현재 전세계 각국 정부들이 신종플루 위험성을 과대평가하여 지나치게 많은 백신을 주문하여 비축함으로써 사용하지 못한 백신이 너무 많이 남았다는 대중들의 비난이 쇄도하고 있는 상황입니다.

WHO의 권고가 이러한 문제를 초래했는데요, 로슈, GSK,  노바티스 등 다국적 거대 제약회사들의 이윤을 위해 WHO가 가짜 신종플루 대유행 경고를 발령했다는 의혹이 제기되어 조사가 진행되고 있는 상황입니다.

1918년 인플루엔자(속칭 스페인독감)의 대유행으로 5천만명의 사람이 사망한 것에 비해 이번 2009 돼지독감(신종플루) 바이러스에 의한 사망자는 1만8천명에 불과합니다.  해마다 계절성 독감으로 사망하는 사람이 35만명 가량 되었던 사실에 견주어 볼 때, 신종플루는 위험은 지나치게 과장된 것이 틀림없습니다.

WHO는 거대 제약회사와 유착의혹으로 스스로의 권위를 땅에 떨어뜨렸는데요, 결국 이러한 피해는 전세계 가난한 국가의 민중들에게 고스란히 전가될 것입니다.

과연 전세계 어느 누가 가난한 국가들의 질병을 경감시키기 위해 재정적 지원을 요청하는 양치기 소년 WHO의 말을 따르겠습니까?

전문가 조사패널의 보고서는 2010년 5월에 WHO 회원국가들에게 제출될 예정이고, 최종보고서는 내년에 출판될 예정이라고 합니다.

================================


Chair seeks to tackle bias in WHO swine flu review







GENEVA – The head of an expert group brought in to review the World Health Organization‘s response to the swine flu outbreak said Wednesday that some members of the panel would inevitably be biased because of their close links to the global body or national governments.


Harvey Fineberg, president of the Institute of Medicine in Washington, said the 29-member panel will try to deal with this problem by exposing conflicts of interest and — where appropriate — recusing members from specific discussions.


Faced with persistent criticism over its handling of the pandemic, WHO convened the panel Monday with instructions to conduct a “credible and independent review” of how the global body and national authorities responded to the outbreak. Critics say many panelists are trusted WHO advisers and government employees who could end up whitewashing any failures.


“We are actually still in the process of identifying all the possible sources of bias,” Fineberg told reporters in Geneva. “This is a committee that is composed of a lot of individuals who have done a lot of things in public health.”


At least ten panelists flown in by WHO are past or current advisers to the organization. Twenty four members of the panel are government employees.


All were selected by WHO Director-General Margaret Chan from among a roster of 200 experts proposed by the governments they are also meant to scrutinize.


“The WHO generally has a history of policy reviews and commissions reaching predetermined conclusions and this one looks like it fits that pattern,” said Philip Stevens of the London-based think tank International Policy Network.


Public anger is growing in many countries as vast stocks of unused vaccines, bought by governments at WHO’s recommendation, near their expiry date. Stevens said WHO’s repeated requests for money to help poor countries fight the pandemic also were questionable, but doubted they would be criticized.


“They were erroneously invoking the specter of the 1918 pandemic in which 50 million died around the world,” he said.


So far about 18,000 deaths from the A(H1N1) virus have been confirmed globally, out of millions of infections.


One issue that has received a lot of attention is WHO’s alert system for pandemic threat levels, or phases. Critics have complained that WHO was too quick to move to phase six — the highest level indicating a global outbreak.


“If most of these experts were part of the expert group that developed the WHO pandemic alert phase system, then this panel will simply be a whitewashing panel,” said James Chin, a retired professor of epidemiology at the University of California at Berkeley and former WHO official who fell out with the global body over its HIV and AIDS policies.


According to WHO documents, at least seven panelists contributed to the guidelines on pandemic phases.


Fineberg said the panel would examine the need to include severity along with geographical spread in future descriptions of disease outbreaks — something many health experts and governments have criticized WHO for failing to do with swine flu.


Michael Osterholm, a prominent expert on global flu outbreaks with the University of Minnesota, said much of the criticism directed at WHO and governments could be blamed on persistent public misunderstanding of the situation, due in part to poor communication by officials.


Osterholm said he was confident the review panel had the best technical experts for the task and their work would be carefully examined by others in the scientific community.


The experts’ initial findings will be presented to WHO member states in May. A final report will be published next year.


===================

[참고] 하비 파인버그(Harvey Fineberg)

Harvey Fineberg is President of the Institute of Medicine. He served as Provost of Harvard University from 1997 to 2001, following thirteen years as Dean of the Harvard School of Public Health. He has devoted most of his academic career to the fields of health policy and medical decision making. His past research has focused on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations.


Dr. Fineberg helped found and served as president of the Society for Medical Decision Making and also served as consultant to the World Health Organization.


At the Institute of Medicine, he has chaired and served on a number of panels dealing with health policy issues, ranging from AIDS to new medical technology. He also served as a member of the Public Health Council of Massachusetts (1976-1979), as chairman of the Health Care Technology Study Section of the National Center for Health Services Research (1982-1985), and as president of the Association of Schools of Public Health (1995-1996).


Dr. Fineberg is co-author of the books Clinical Decision Analysis, Innovators in Physician Education, and The Epidemic that Never Was, also published under the title The Swine Flu Affair, an analysis of the controversial federal immunization program against swine flu in 1976. He has co-edited several books on such diverse topics as AIDS prevention, vaccine safety, and understanding risk in society. He has also authored numerous articles published in professional journals. In 1988, he received the Joseph W. Mountin Prize from the Centers for Disease Control and the Wade Hampton Frost Prize from the Epidemiology Section of the American Public Health Association. Dr. Fineberg earned an A.B. in 1967 from Harvard College, an M.D. in 1971 from Harvard Medical School, a Master of Public Policy from the Kennedy School of Government in 1972, and a Ph.D. in Government from Harvard’s Graduate School of Arts and Sciences in 1980.


Fineberg served his medical residency at Beth Israel Hospital, Boston, and was a fellow in Harvard’s Society of Fellows. He worked as a practicing physician at two Boston-area health centers from 1974 to 1984. He taught at the Kennedy School of Government from 1973 to 1981, and served on the faculty at the Harvard School of Public Health from 1973 to 1984, when he became the school’s dean.


Dr. Fineberg is married to Mary E. Wilson, a former associate professor at Harvard Medical School and Harvard School of Public Health.

댓글 남기기

이메일은 공개되지 않습니다.

다음의 HTML 태그와 속성을 사용할 수 있습니다: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>